We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MFIN:NASDAQMedallion Financial Corp. Analysis

Data as of 2026-05-20 - not real-time

$9.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Medallion Financial is trading at $9.32, just below its 20‑day SMA of $9.39 but above the 50‑day SMA of $9.10, indicating a modest short‑term weakness within a neutral overall trend. The RSI of 49.4 and a bullish MACD histogram of 0.003 suggest momentum is neither overbought nor oversold, while increasing volume supports the recent price action. Valuation metrics are attractive: a trailing PE of 6.3 versus an industry average of 16.5 and a price‑to‑book of 0.53 point to the stock being **undervalued**. The dividend yield of 5.8% is high, yet the negative free‑cash‑flow of $‑57 M and a debt‑to‑equity ratio of 472 raise concerns about dividend sustainability. Recent news highlighted growth in net interest income and loan originations, but also a Q1 earnings miss and a $75 M senior note private placement that adds to leverage. With a 30‑day volatility of 31% and a beta of 1.2, the stock is more volatile than the market, and the $8.85 support level and $10.02 resistance level frame a tight trading range.
Fundamentally, revenue declined 6.4% year‑over‑year and operating margins remain solid at 45%, but the company carries $2.39 B of debt against a market cap of $222 M, creating a high financial risk profile. The dividend payout ratio of 32% of earnings appears manageable in the short term, but the negative free cash flow and leverage could pressure payouts if earnings falter. The recent senior note issuance provides liquidity but also deepens the debt burden, suggesting that any upside will depend on continued loan growth and effective credit risk management. Overall, the stock offers a value‑oriented entry point with a strong yield, but investors must weigh the significant leverage and earnings volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near $8.85 support with neutral trend
  • Q1 earnings miss and high leverage
  • Increasing volume supporting short‑term stability

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Undervalued valuation metrics (PE 6.3 vs industry 16.5)
  • High dividend yield offset by negative free cash flow
  • Elevated debt‑to‑equity ratio increasing financial risk

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive value valuation and strong dividend yield
  • Potential upside from loan originations and net interest income growth
  • Risk mitigated if debt reduction and cash flow improvement materialize

Key Metrics & Analysis

Financial Health

Revenue Growth-6.40%
Profit Margin10.35%
P/E Ratio6.3
ROE10.27%
ROA3.68%
Debt/Equity471.70
P/B Ratio0.5
Op. Cash Flow$134.5M
Free Cash Flow$-57115624
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI49.4
Support$8.85
Resistance$10.02
MA 20$9.39
MA 50$9.10
MA 200$9.92
MACDBullish
VolumeIncreasing
Fear & Greed Index89.18

Valuation

Target Price$11.25
Upside/Downside20.71%
GradeUndervalued
TypeValue
Dividend Yield5.82%

Risk Assessment

Beta1.20
Volatility31.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.